Strongest adherence to cancer prevention lifestyle recommendations is associated with reductions in disease recurrence and mortality among patients with high-risk breast cancer, according to a study published online May 4 ...
May 5, 2023
0
3
Statins are the most commonly used medication in lowering blood cholesterol, prescribed to tens of millions in the Western world. Statins act through inhibition of the enzyme HMG CoA reductase. Nearly 20% of statin users ...
Mar 21, 2023
0
79
The presence or absence of nonictal allodynia can be used to identify migraine sufferers who will likely respond to galcanezumab, according to a study published online Feb. 14 in Cephalalgia.
Feb 21, 2023
0
15
For patients with newly diagnosed multiple myeloma (MM), mass spectrometry (MS) can monitor treatment response, according to a study published online Jan. 4 in Blood Cancer Journal.
Jan 19, 2023
0
18
An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, drug-resistant ...
Oct 11, 2022
0
16
Bilateral theta burst stimulation (TBS) is noninferior to standard bilateral repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in older adults, according to a study published online Sept. ...
Sep 28, 2022
0
2
For high-risk patients with mild-to-moderate COVID-19 during the Omicron epoch, bebtelovimab seems to be a reliable treatment option, according to a study published online Sept. 17 in the Journal of Infectious Diseases.
Sep 20, 2022
0
22
In utero exposure to commonly prescribed antipsychotic medications does not seem to meaningfully increase the risk for neurodevelopmental disorders (NDD) in offspring, according to a study published online March 28 in JAMA ...
Mar 31, 2022
0
17
The results from the major phase III OlympiA trial shows the drug improves survival rates in women who have inherited faults in their BRCA1 or BRCA2 genes.
Mar 17, 2022
0
23
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer's Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against the BA.2 variant of SARS-CoV-2, the virus that causes COVID-19.
Mar 10, 2022
0
123
